Page last updated: 2024-12-08

vibo-quercitol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

vibo-quercitol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID441438
CHEMBL ID37104
CHEMBL ID3351099
CHEBI ID37600
SCHEMBL ID5151166
SCHEMBL ID17925160
MeSH IDM0508929

Synonyms (24)

Synonym
1-d-3-deoxy-myo-inositol
CHEBI:37600 ,
1l-1,2,4/3,5-cyclohexanepentol
d-1-deoxy-myo-inositol
(1r,2r,3r,4s,5r)-cyclohexane-1,2,3,4,5-pentol
488-76-6
(-)-viburnitol
C08259
Q0069
(-)-vibo-quercitol
CHEMBL37104
(1r,2r,4s,5r)-cyclohexane-1,2,3,4,5-pentol
(1r,2s,4r,5r)-cyclohexane-1,2,3,4,5-pentol
SCHEMBL5151166
vibo-quercitol
W-202865
DTXSID10331579
l-chiro-inositol, 1-deoxy-
CHEMBL3351099
SCHEMBL17925160
(1r,2r,3r,4s,5r)-cyclohexane-1,2,3,4,5-pentaol
FS-9928
Q27104416
AKOS040755970
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID74520Inhibitory activity against Glucosylceramidase in mouse liver; Significant activity1999Bioorganic & medicinal chemistry letters, Jun-07, Volume: 9, Issue:11
Synthesis and evaluation of glucocerebrosidase inhibitory activity of anhydro deoxyinositols from (+)-epi- and (-)-vibo-quercitols.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.13 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]